PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 10/6

PharmD_KS's avatar
PharmD_KS
Oct 05, 2025
∙ Paid
1
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ which includes a free video should be reviewed prior to this. Market Analysis for the Week of 10/5

There is a 7-day free trial available for the newsletter so feel free to use that to review the starter kit, weekly plan, and plan for tomorrow. I cannot do trials for the Discord at this time.

SPY 0.00%↑

Because of the presence of a large NQ seller on Thursday I came into Friday in the mood to sell the indices and NQ in particular. From the premarket update:

NQ made for a nice short in the morning while ES (driven by non-tech YM type names) was quite strong. After reaching the weekly 6798-6801 level, ES saw some heavy selling come into the tape along with NQ. NQ took out Friday’s low which was my slight lean, while ES did not make it there because of its early strength.

Despite the heavy selling Friday afternoon, both indices broadly held where they needed to as described on Thursday night. As discussed in the weekly plan, we do have a “trap door” setup on NQ in particular. We therefore have some competing factors coming into Monday and it will therefore be critical in setting the tone for this week.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to PharmD Capital Trading with PharmD_KS to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture